TABLE 3.
GROUP | CHARACTERISTICS | MEDIAN CREATININE |
RANGE | MEDIAN DAYS TERMINAL |
RANGE |
---|---|---|---|---|---|
C | PURE CAMR: NO NK NO CD3 | 1.5 | 1.1–4.6 | 815 | 477–2023 |
D | MIXED: CAMR + NK FCGR3A | 2.8 | 0.9–5.1 | 386 | 71–1379 |
E | MIXED:CAMR + NK FCGR3A > CD3 | 3 | 1.0–8.0 | 470 | 75–838 |
F | MIXED: CAMR + NK + CD3 | 2.8 | 0.8–8.7 | 378 | 110–930 |
G | STRONG TCMR: SOME NK | 3 | 1.3–14 | 173 | 58–282 |
H | WEAKER TCMR: SOME NK | 1.2 | 1.0–3.9 | 164 | 69–910 |
Terminal graft survival for Group C is significantly different from Groups D, E, or F: FDRPV < 0.01
Terminal graft survivals and creatinines for Groups G and H are signficantly different: FDRPV < 0.03